https://scholars.lib.ntu.edu.tw/handle/123456789/540539
Title: | Transfusion-dependent thalassaemic patients with renal Fanconi syndrome due to deferasirox use | Authors: | GWO-TSANN CHUANG I-JUNG TSAI Tsau, Yong-Kwei MENG-YAO LU |
Keywords: | Fanconi syndrome; Thalassaemia; deferariox; hypophosphataemia; renal tubular acidosis | Issue Date: | Dec-2015 | Publisher: | WILEY-BLACKWELL | Journal Volume: | 20 | Journal Issue: | 12 | Start page/Pages: | 931 | Source: | Nephrology (Carlton, Vic.) | Abstract: | Deferasirox is a new oral iron chelating agent with several cases reporting renal adverse events in recent years. Our aim was to identify the incidence of deferasirox-related Fanconi syndrome (FS) and its risk factors. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/540539 | ISSN: | 1320-5358 | DOI: | 10.1111/nep.12523 | SDG/Keyword: | creatinine; deferasirox; benzoic acid derivative; deferasirox; iron chelating agent; triazole derivative; Article; child; controlled study; creatinine blood level; disease association; drug dose reduction; drug safety; Fanconi renotubular syndrome; female; human; hypophosphatemia; incidence; kidney tubule acidosis; major clinical study; male; priority journal; retrospective study; school child; thalassemia; treatment duration; treatment withdrawal; adolescent; blood; blood transfusion; chemically induced; Fanconi Syndrome; hypophosphatemia; kidney tubule acidosis; preschool child; risk factor; Taiwan; thalassemia; university hospital; young adult; Acidosis, Renal Tubular; Adolescent; Benzoates; Blood Transfusion; Child; Child, Preschool; Fanconi Syndrome; Female; Hospitals, University; Humans; Hypophosphatemia; Incidence; Iron Chelating Agents; Male; Retrospective Studies; Risk Factors; Taiwan; Thalassemia; Triazoles; Young Adult |
Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.